Traws Pharma Inc. share price logo

Traws Pharma Inc.

NASDAQ: TRAW

Small Cap

$0.85

+0.05

(+6.49%)

as on

Traws Pharma Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    $0.75
    $0.85
    downward going graph

    11.76%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.64
    $3.27
    downward going graph

    24.71%

    Downside

    284.12%

    Upside

    downward going graph

Traws Pharma Inc. share price movements today

Previous Close
$0.80
Open
$0.80
Volume
1.5M
Day's Low - High
$0.75 - $0.85
52 Week Low - High
$0.64 - $3.27

Traws Pharma Inc. Historical Returns

1 Month Return
-46.52 %
3 Month Return
-61 %
1 Year Return
-48.47 %
3 Year Return
0 %
5 Year Return
0 %

Traws Pharma Inc. Stock Fundamentals & Key Indicators

Check Traws Pharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.9M

EPS (TTM)

-1.82

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.5M

Revenue (TTM)

2.7M

Profit Margin

0.00%

Return On Equity TTM

-5639.19%

Traws Pharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Traws Pharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Traws Pharma Inc. image
Traws Pharma Inc.
BUY$12.9MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Traws Pharma Inc. Stock including INR - Dollar returns

The Traws Pharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Traws Pharma Inc. investment value today

Current value as on today

₹56,115

Returns

-₹43,885

(-43.89%)

Returns from Traws Pharma Inc. Stock

-₹48,485 (-48.48%)

Dollar Impact

₹4,599 (+4.6%)

Analyst Recommendation on Traws Pharma Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Traws Pharma Inc.. Average target price of $8

Traws Pharma Inc. Share Price Target

Get share price movements and forecasts by analysts on Traws Pharma Inc..

What analysts predicted

89.38%UPSIDE

Target Price

$8

Current Price

$0.85

Analyzed by

8 Analysts

Target

$8.00

Traws Pharma Inc. target price $8, a slight upside of 89.38% compared to current price of $0.85. According to 8 analysts rating.

Indian Investors' Interest in Traws Pharma Inc. Stock

Search interest for Traws Pharma Inc. Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-70% versus previous 30 day period

Traws Pharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
2
-
-
0
Gross Profit
0
0
0
0
0
0
2
-
-
0
Operating Income
-9
-5
-5
-8
-8
-5
-1
-4
-7
-6
EBITDA
-9
-5
-5
-8
-8
21
-1
-3
-
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-4
-4
-8
-8
21
0
-3
-7
-7
Income Tax Expense
0
0
-
-
-
-
-
-
-
-
Net Income
-8
-4
-4
-8
-8
15
0
-3
-7
-7
Net Profit Margin
-7896.46%
-8898.21%
-8898.21%
-14868.42%
-14868.42%
26461.40%
-33.48%
0.00%
0.00%
-12468.42%

Traws Pharma Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
0
1
2
0
0
0
0
0
2
Gross Profit
5
0
1
2
0
0
0
0
0
2
Operating Income
-23
-25
-23
-21
-24
-16
-19
-20
-49
-17
EBITDA
-19
-23
-20
-21
-24
-16
-19
-20
-166
-17
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
0
0
0
0
0
0
Income Before Tax
-19
-24
-20
-21
-25
-16
-18
-18
-166
9
Income Tax Expense
0
0
0
0
0
0
0
0
-
-
Net Income
-19
-24
-20
-21
-25
-16
-18
-18
-54
9
Net Profit Margin
-354.62%
-3061.25%
-1675.33%
-985.02%
-10890.48%
-7151.77%
-8391.15%
-8384.07%
-24192.04%
328.67%

Traws Pharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-4
-123
-8
81
21
0
-3
-5
-7
Operating Cash Flow
-4
-9
-11
-4
-5
-5
-4
-2
-2
Investing Cash Flow
-
-3
-
-
-
-
-2
-
-2
Financing Cash Flow
-
13
-
19
0
3
0
0
1
Change in Cash
-4
0
-11
15
-5
-2
-6
-2
0

Traws Pharma Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-20
-21
-25
-16
-18
-18
-54
9
Operating Cash Flow
-23
-22
-20
-23
-19
-16
-17
-29
-18
Investing Cash Flow
-
-
0
0
-
-
0
-3
-2
Financing Cash Flow
6
35
26
19
55
-
-
33
3
Change in Cash
-17
12
5
-3
36
-16
-17
0
-17

Global Institutional Holdings in Traws Pharma Inc.

Funds
Holdings
Two Sigma Investments LLC
0.13%
XTX Topco Ltd
0.28%
Citadel Advisors Llc
0.16%
Adage Capital Partners Gp LLC
4.82%
Ikarian Capital, LLC
4.48%
See all

Traws Pharma Inc. News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:03 PM

    -

    Traws Pharma reports Q3 2025 results, highlighting revenue growth and advancements in clinical programs for respiratory viral diseases.

Insights on Traws Pharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.44M → -7.10M (in $), with an average increase of 4.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 68.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.73M → 57.0K (in $), with an average decrease of 97.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TRAW stock has moved down by -33.6%

About Traws Pharma Inc.

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It is also developing narazaciclib, a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other anti-cancer therapies; and rigosertib, which is administered alone or in combination for investigation in various cancers. It has a license agreement with SymBio Pharmaceuticals Limited, Pint International SA, Viriom, Inc., Knight Therapeutics Inc., Specialised Therapeutics Asia Pte. Ltd., and Temple University. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
OrganisationTraws Pharma Inc.
Headquarters12 Penns Trail, Newtown, PA, United States, 18940
IndustryBiotechnology
CEODr. Iain D. Dukes DPHIL, M.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Traws Pharma Inc.

Name

Title

Dr. Nikolay Savchuk Ph.D.

COO & Director

Dr. Charles David Pauza Ph.D.

Chief Scientific Officer of Virology

Mr. Charles Parker

Chief Financial Officer

Dr. Victor Mandia Moyo M.D.

Chief Medical Officer of Oncology

Dr. Robert R. Redfield M.D.

Chief Medical Officer

Dr. Iain D. Dukes DPHIL, M.A., Ph.D.

CEO, Secretary & Director

FAQs

What is Traws Pharma Inc. share price today?

Traws Pharma Inc. share price today is $0.85 as on at the close of the market. Traws Pharma Inc. share today touched a day high of $0.85 and a low of $0.75.

What is the 52 week high and 52 week low for Traws Pharma Inc. share?

Traws Pharma Inc. share touched a 52 week high of $3.27 on and a 52 week low of $0.64 on . Traws Pharma Inc. stock price today i.e. is closed at $0.85,which is 73.97% down from its 52 week high and 32.81% up from its 52 week low.

What is Traws Pharma Inc.'s market capitalisation today?

Traws Pharma Inc. market capitalisation is $0.00T as on .

How to invest in Traws Pharma Inc. Stock (TRAW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Traws Pharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Traws Pharma Inc. Shares that will get you 1.7647 shares as per Traws Pharma Inc. share price of $0.85 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Traws Pharma Inc. Stock (TRAW) from India?

Indian investors can start investing in Traws Pharma Inc. (TRAW) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Traws Pharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Traws Pharma Inc. share’s latest price of $0.85 as on June 19, 2026 at 8:46 am IST, you will get 11.7647 shares of Traws Pharma Inc.. Learn more about fractional shares .